Tissue-plasminogen activator stimulates endothelial cell migration in wound assays.
The ability of tissue plasminogen activator (tPA) to induce human umbilical vein endothelial (HUVE) cell migration was studied using an in vitro, serum-free wound assay system. At pharmacological doses, tPA stimulated HUVE cell migration dose-dependently. Treatment of cells with epsilon amino caproic acid (EACA) to detach cell-surface and extracellular matrix bound plasminogen, which could lead to plasmin generation, resulted in increased HUVEcell migration on stimulation with tPA.Plasminogen activator inhibitor-1 (PAI-1), a natural plasminogen activator inhibitor, abolished tPA-induced HUVEcell migration. These results demonstrate for the first time that tPA is capable of stimulating endothelial cell migration in wound assays and this effect is susceptible to PAI-1 inhibition.
Inyang
A L
AL
INSERM U150, Hopital Lariboisiere, Paris, France.
Tobelem
G
G
D002465:Cell Movement / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007700:Kinetics; D015849:Plasminogen Inactivators / Q000494:pharmacology; D010959:Tissue Plasminogen Activator / Q000494:pharmacology*; D014947:Wounds and Injuries / Q000503:physiopathology*
D015849:Plasminogen Inactivators; D010959:Tissue Plasminogen Activator